Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

[Analysis of Survival Time and Other Event Times - What Does the Surgeon Need to Know?].

Zentralblatt fur Chirurgie·2014
Same author

Collection, synthesis, and interpretation of evidence: a proof-of-concept study in COPD.

Statistics in medicine·2013
Same author

Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2009

Related Experiment Video

Updated: May 29, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Time-to-event analysis with treatment arm selection at interim.

L Di Scala1, E Glimm

  • 1Novartis Pharma AG, Basel, Switzerland. lilla.di_scala@novartis.com

Statistics in Medicine
|September 8, 2011
PubMed
Summary

This study explores adaptive trial designs for oncology, using Bayesian methods for treatment selection based on survival and progression data. It evaluates statistical approaches to ensure reliable efficacy testing and control of type I errors.

More Related Videos

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Related Experiment Videos

Last Updated: May 29, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Oncology

Background:

  • Adaptive trial designs offer flexibility in clinical research.
  • Treatment arm selection is crucial in oncology trials with multiple endpoints.
  • Balancing efficacy and type I error control is essential for valid trial conclusions.

Purpose of the Study:

  • To apply an adaptive design for treatment arm selection in an oncology trial.
  • To combine survival and disease progression data for interim analysis.
  • To evaluate statistical methods for maintaining type I error control at final analysis.

Main Methods:

  • Utilized an adaptive design for treatment arm selection at an interim analysis.
  • Employed Bayesian predictive power to integrate primary (survival) and secondary (disease progression) endpoints.
  • Investigated four statistical approaches (Bonferroni, Dunnett-like, conditional error function, combination p-value) for final analysis.

Main Results:

  • The study assessed the power and type I error control of different statistical approaches under various conditions.
  • Bayesian predictive power was used to combine evidence from survival and progression endpoints for arm selection.
  • Frequentist statistical tests were applied to the survival endpoint in the final analysis.

Conclusions:

  • Adaptive designs can effectively manage treatment arm selection in oncology trials.
  • The chosen statistical methods impact the power and validity of efficacy conclusions.
  • Careful consideration of statistical approaches is necessary for robust trial outcomes in adaptive oncology studies.